MedTrace Logo

A Study of HD-tDCS and Cognitive Training to Improve Cognitive Function in MCI

NCT04246164 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2026-04-23

Study results available
· View outcomes & findings →

Summary

The primary objective of this project is to assess the feasibility of multi-field, extended HD-tDCS (MFE-HD-tDCS) with simultaneous computerized CT as a viable intervention to improve cognitive function in patients with MCI. This double-blinded, randomized pilot clinical trial of repetitive daily HD-tDCS/sham HD-tDCS, administered in combination with CT to subjects with MCI in 3 monthly blocks of 5 daily sessions for a total of 15 sessions will enroll 8 participants.

Conditions

Interventions

DEVICE

HD-tDCS combined with CT

HD-tDCS treatments will be administered during a cognitive training session.

DEVICE

sham HD-tDCS combined with CT

sham-HD-tDCS treatments will be administered during a cognitive training session.

Sponsors & Collaborators

  • University of Wisconsin, Madison

    collaborator OTHER

  • Medical College of Wisconsin

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-25
Primary Completion
2023-02-23
Completion
2023-02-23
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04246164 on ClinicalTrials.gov